Cite

HARVARD Citation

    Kim, M. et al. (2021). CTIM-21. AN AGE-SPECIFIC BIOMARKER IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH RADIATION, NIVOLUMAB AND BMS-986205. Neuro-oncology. p. vi54. [Online]. 
  
Back to record